References
- Dodds A. J., O'Reilly M. J. G., Yates C. J. P., Cotton L. T., Flute P. T., Dormandy J. A. Haernorheological response to plasma exchange in Raynaud's Syndrome. Br. Med. J 1979; 2: 1186–11871. Dodds A. J., O'Reilly M. J. G., Yates C. J. P., Cotton L. T., Flute P. T., Dormandy J. A. Haernorheological response to plasma exchange in Raynaud's Syndrome. Br. Med. J 1979; 2: 1186–1187
- Ehrly A. M. Modifications of erythrocyte deformability by pentoxifylline. Med. Welt 1975; 26: 2300–23012. Ehrly A. M. Modifications of erythrocyte deformability by pentoxifylline. Med. Welt 1975; 26: 2300–2301
- Feine-Haake G. A double-blind therapeutic trial of BL 191 RD in patients with disturbed circulation. Fortschr. Med 1977; 95: 48–513. Feine-Haake G. A double-blind therapeutic trial of BL 191 RD in patients with disturbed circulation. Fortschr. Med 1977; 95: 48–51
- Grigoleit H.-G., Porsche E., Stefanovich V., Jacobi G., Lahnham A. The effect of pentoxifylline on red cell flexibility in healthy subjects after administration of ‘Trental’ 400. Pharmatherapeutica 1976; 1: 241–2474. Grigoleit H.-G., Porsche E., Stefanovich V., Jacobi G., Lahnham A. The effect of pentoxifylline on red cell flexibility in healthy subjects after administration of ‘Trental’ 400. Pharmatherapeutica 1976; 1: 241–247
- Heinrich H., Ott M. Vasodilators and blood viscosity. Herz/Kreislauf 1974; 6: 542–5465. Heinrich H., Ott M. Vasodilators and blood viscosity. Herz/Kreislauf 1974; 6: 542–546
- Jarrett P. E. M., Moreland M., Browse N. L. The effect of oxpentifylline (‘Trental’) on fibrinolytic activity and plasma fibrinogen levels. Curr. Med. Res. Opin 1977; 4: 492–4956. Jarrett P. E. M., Moreland M., Browse N. L. The effect of oxpentifylline (‘Trental’) on fibrinolytic activity and plasma fibrinogen levels. Curr. Med. Res. Opin 1977; 4: 492–495
- Pemler K., Penth B., Adarns H. J. Pentoxifylline therapy in the treatment of chronic leg ulcers. Fortschc Med 1979; 97: 1019–10227. Pemler K., Penth B., Adarns H. J. Pentoxifylline therapy in the treatment of chronic leg ulcers. Fortschc Med 1979; 97: 1019–1022
- Rudofsky G., Brock F. E., Ulrich M., Nobbe F. Treatment of patients with occlusive arterial disease (Stage II) with oxpentifylline. Haemodynamic and ergornetric findings. Med. Klin 1979; 74: 1093–10968. Rudofsky G., Brock F. E., Ulrich M., Nobbe F. Treatment of patients with occlusive arterial disease (Stage II) with oxpentifylline. Haemodynamic and ergornetric findings. Med. Klin 1979; 74: 1093–1096
- Schubotz R. Double-blind trial of pentoxifylline in diabetics with peripheral vascular disorders. Pharmatherapeutica 1976; 1: 172–1799. Schubotz R. Double-blind trial of pentoxifylline in diabetics with peripheral vascular disorders. Pharmatherapeutica 1976; 1: 172–179
- Schubotz R., Muhlfellner O. The effect of pentoxifylline on erythrocyte deformability and on phosphate fatty acid distribution in the erythrocyte membrane. Curr. Med. Res. Opin 1977; 4: 609–61710. Schubotz R., Muhlfellner O. The effect of pentoxifylline on erythrocyte deformability and on phosphate fatty acid distribution in the erythrocyte membrane. Curr. Med. Res. Opin 1977; 4: 609–617
- Stefanovich V., Porsche E., Muller E. On the influence of pentoxifylline on the permeability of rat erythrocytes for methyl 0 glucose. Arzneim. Forsch 1979; 29: 757–76011. Stefanovich V., Porsche E., Muller E. On the influence of pentoxifylline on the permeability of rat erythrocytes for methyl 0 glucose. Arzneim. Forsch 1979; 29: 757–760
- Volker D. Haemorheological investigations in patients with vascular disease undergoing treatment with pentoxifylline. Pharmatherapeutica 1976; 1: 154–15912. Volker D. Haemorheological investigations in patients with vascular disease undergoing treatment with pentoxifylline. Pharmatherapeutica 1976; 1: 154–159